Torrent Pharmaceuticals Limited (TORNTPHARM) Balance Sheet

A balance sheet shows what a company owns and owes, and shareholders' equity, at a single point in time.

Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, marketing, and distribution of branded and generic pharmaceutical formulations in India, the United States, Brazil, Germany, Malta, and internationally.

Total Assets Chart for Torrent Pharmaceuticals Limited

Torrent Pharmaceuticals Limited (TORNTPHARM) total assets for FY2026 were INR 443.1B, a 195.6% change from FY2025. Torrent Pharmaceuticals Limited's total assets grew from INR 7.1B in 2005 to INR 443.1B in 2026 (6135.5% over 21 years). Total assets compound annual growth rate: 5-year CAGR of 25.8%, 10-year CAGR of 17.3%, 20-year CAGR of 21.2%.

The most recent 3 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.

Total Assets (Indian Rupees)

R&D as % of Revenue

Compare with

Key Stats

Market Cap
₹1.73T
Implied Share Price
₹4550.00
Enterprise Value
₹1.85T
Revenue (TTM)
₹174.00B
EBITDA
₹57.12B
Profit Margin
12.21%
Trailing P/E
76.86
Forward P/E
56.50
Price/Book (MRQ)
20.52
Price/Sales (TTM)
9.95
EV/EBITDA
36.87
EV/Revenue
11.95
Dividend Yield
0.00%
Book Value
₹483.41
Free Cash Flow (FY2026)
₹19.55B
Free Cash Flow Yield
1.13%

Snapshot as of 26th October 2026 — not point-in-time controlled, may lag the live market by a few days.